Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Vomiting 1Shoulder Pain 1Postoperative Nausea and Vomiting 1Muscular Atrophy 1Lymphedema 1Glioma 1Gastrointestinal Neoplasms 1Edema 1Colorectal Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Electric Stimulation × Clear all
NCT07465796 2026-06-03

CIPHER

Coherence Neuro Australia Pty Limited

Phase NA Recruiting
10 enrolled
CNS

Glioma, Neoplasms

NCT02158832 2017-08-30

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

McMaster University

Phase NA Withdrawn
Breast

Breast Neoplasms, Edema, Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡